PACGET 260MG

Pacget 260mg Injection is a chemotherapy drug that contains paclitaxel as its active ingredient. It is utilized for the treatment of breast cancer, non-small cell lung cancer, ovarian cancer, and AIDS (Acquired Immuno-Deficiency Syndrome). Cancer is characterized by the rapid and uncontrolled division and growth of cells. This medication is not advised for adolescents and children under 18 years of age.

Pacget 260mg Injection can be administered alone or in conjunction with other anticancer therapies. This chemotherapy agent is contraindicated for individuals with severe liver issues, uncontrolled infections, or low counts of white blood cells or platelets. If you have heart conditions, consult your doctor prior to using this medication.

The administration of this drug may lead to severe allergic reactions. It is important to use effective birth control during treatment and for at least six months following the final dose. Pacget 260mg Injection may pose risks to patients with a history of alcoholism, as it contains alcohol.